NCT07799883 Reducing Chronic Pain Following Cesarean Delivery
| NCT ID | NCT07799883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-10-26 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-10-26 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will evaluate the feasibility and acceptability of delivering Empowered Relief (ER), a single-session pain relief skills class, to postpartum women with ongoing pain and/or pain interference following cesarean delivery. Participants will receive ER in addition to standard postpartum care and will be followed through 12 weeks postpartum.
Eligibility Criteria
Inclusion Criteria: 1. Complete informed consent. 2. Age 18 years or above. 3. Postpartum woman who delivered by cesarean within the Stanford Healthcare system. 4. Viable birth (singleton or multiple gestation). 5. All maternal demographics and complications are eligible: parity, medical conditions (e.g., pre-eclampsia, gestational diabetes), and post-surgical complications (e.g., hysterectomy, ICU admission, extended hospital stay). 6. All neonatal complications are eligible (e.g., NICU admission, extended hospital stay) 7. Attend the 6-week postpartum clinic visit. 8. Any pain intensity (numeric rating scale \[NRS\] \>0/10) and/or pain interference (PROMIS pain interference 8a score \>8) at 6 weeks postpartum. 9. English fluency, with ability to read and write. 10. Ability to adhere to and complete study procedures. 11. Access to a smart device if attending ER session via Zoom. Exclusion Criteria: 1. Age under 18 years. 2. Cognitive impairment or psychological factors that would preclude comprehension of study material or full participation. 3. Unable or unwilling to provide informed consent. 4. Chronic pain prior to pregnancy.
Frequently Asked Questions
Who can join the NCT07799883 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07799883 currently recruiting?
Yes, NCT07799883 is actively recruiting participants. Visit ClinicalTrials.gov or contact Stanford University to inquire about joining.
Where is the NCT07799883 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07799883 clinical trial?
NCT07799883 is sponsored by Stanford University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.